Korean J Reprod Med.  2010 Sep;37(3):239-244.

Comparison between GnRH Antagonist and Agonist Long Protocols in Poor Responders

Affiliations
  • 1Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul National University, Seoul, Korea.
  • 2Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University, Seoul, Korea.
  • 3Department of Obstetrics and Gynecology, Incheon Medical Center, Incheon, Korea.

Abstract


OBJECTIVE
The objective of this retrospective study was to compare the in vitro fertilization (IVF) outcomes of gonadotropinreleasing hormone (GnRH) agonist and GnRH antagonist protocols in poor responders. METHODS: A total of 172 cycles in subjects with less than 5 oocytes retrieved treated with either GnRH agonist long protocols or antagonist protocols were included. The outcome variables such as numbers of growing follicles and retrieved oocytes, and the fertilization rate were evaluated as the main outcome measures. RESULTS: There was no difference in regard to the numbers of growing follicles and oocytes, and fertilization rate between the two groups. E2 level on Day 7/8, mean gonadotropin dose, and the days of stimulation were shown to be statistically different (p<0.01, respectively). CONCLUSION: Considering that similar results were observed with less time and gonadotropin dose, GnRH antagonist protocol may be considered as a preferable choice over GnRH agonist protocols in poor responders.

Keyword

Poor responder; Gonadotropin-releasing hormone agonist; GnRH antagonist; Controlled ovarian hyperstimulation; in vitro fertilization

MeSH Terms

Fertilization
Fertilization in Vitro
Gonadotropin-Releasing Hormone
Gonadotropins
Oocytes
Outcome Assessment (Health Care)
Retrospective Studies
Gonadotropin-Releasing Hormone
Gonadotropins
Full Text Links
  • KJRM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr